Cardiovasc Diabetol
From Bioblast
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Journal title and website | Cardiovascular Diabetology |
---|
Publications
Reference | Published | View | |
---|---|---|---|
Yurista 2020 Cardiovasc Diabetol | Yurista SR, Silljรฉ HHW, Rienstra M, de Boer RA, Westenbrink BD (2020) Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes? Cardiovasc Diabetol 19:5. | 2020 | PMID: 31910841 Open Access |
Shao 2019 Cardiovasc Diabetol | Shao Q, Meng L, Lee S, Tse G, Gong M, Zhang Z, Zhao J, Zhao Y, Li G, Liu T (2019) Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induce diabetic rats. Cardiovasc Diabetol 18:165. | 2019 | PMID: 31779619 Open Access |
Zhang 2018 Cardiovasc Diabetol | Zhang X, Zhang Z, Yang Y, Suo Y, Liu R, Qiu J, Zhao Y, Jiang N, Liu C, Tse G, Li G, Liu T (2018) Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits. Cardiovasc Diabetol 17:160. | 2018 | PMID: 30591063 Open Access |
Hughey 2013 Cardiovasc Diabetol | Hughey CC, Ma L, James FD, Bracy DP, Wang Z, Wasserman DH, Rottman JN, Hittel DS, Shearer J (2013) Mesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart. Cardiovasc Diabetol 12:128. | 2013 | PMID: 24007410 Open Access |